Animals receiving both, recombinant AnxA2 and tPA had reduced brain hemorrhage and infarct volume and greater cerebral blood flow compared to those treated with tPA alone (Zhu et al., 2010). This evidence concerns the gene PLAT and intracranial hemorrhage.